Tianshui Zhongxing Bio-Technology Co.Ltd(002772) independent director
Prior approval opinions on the proposed reappointment of the audit institution in 2022
Tianshui Zhongxing Bio-Technology Co.Ltd(002772) (hereinafter referred to as “the company”) the 12th meeting of the 4th board of directors will be held on March 23, 2022. This meeting will consider the proposal on the proposed renewal of the company’s audit institution in 2022. In accordance with the guiding opinions on the establishment of independent directors in listed companies, the stock listing rules of Shenzhen Stock Exchange and the articles of association, as the independent director of the company, on the basis of carefully reviewing relevant materials and listening to the reports of relevant personnel, the prior approval opinions on the proposal on the proposed renewal of the company’s audit institution in 2022 are as follows:
After verification, Zhongshen Zhonghuan Certified Public Accountants (special general partnership) has the qualification of securities business and has many years of experience and ability to provide audit services for listed companies. Since it provided audit services for the company, it has been diligent and conscientious, independently issued audit opinions, and better fulfilled the responsibilities and obligations of the audit institution. The company plans to renew its appointment as the company’s audit institution in 2022, which complies with the relevant provisions of laws, regulations and the articles of association, and there is no situation that damages the legitimate rights and interests of the company and shareholders.
Therefore, we agree that the company will renew the appointment of Zhongshen Zhonghuan Certified Public Accountants (special general partnership) as the company’s audit institution in 2022, and agree to submit the proposal to the 12th meeting of the Fourth Board of directors for deliberation. Signature of independent directors: Ju Ming, Liu ya, Dang Lin March 13, 2022
